Macy’s stock surges as company raises 2022 profit outlook despite uncertain retail landscape

Earnings

In this article

A person walks past a Macys store in Hyattsville, Maryland, on February 22, 2022.
Stefani Reynolds | AFP | Getty Images

Macy’s on Thursday reported fiscal first-quarter profits and sales ahead of analysts’ expectations, as shoppers returned to malls to shop for new outfits and luxury goods.

The department store chain, which also owns Bloomingdale’s, reaffirmed its fiscal 2022 sales outlook and raised its profit guidance, expecting stronger credit card revenue for the remainder of the year.

Its shares soared more than 14% in premarket trading on the news.

Macy’s still expects 2022 revenue to be flat to up 1% compared with 2021 levels, which would be a range of $24.46 billion to $24.7 billion.

It now projects earnings, on an adjusted basis, between $4.53 and $4.95 per share, up from a prior range of $4.13 to $4.52.

“While macroeconomic pressures on consumer spending increased during the quarter, our customers continued to shop,” Chief Executive Officer Jeff Gennette said in a press release. He added that the company saw a shift among consumers back into stores and toward clothing for special occasions.

Here’s how Macy’s did in its fiscal first quarter compared with what Wall Street was anticipating, based on a survey of analysts by Refinitiv:

  • Earnings per share: $1.08 adjusted vs. 82 cents expected
  • Revenue: $5.35 billion vs. $5.33 billion expected

For the three-month period ended April 30, Macy’s reported net income of $286 million, or 98 cents per share, compared with net income of $103 million, or 32 cents a share, a year earlier.

Excluding one-time items, it earned $1.08 per share, topping analysts’ expectations for adjusted earnings per share of 82 cents.

Revenue grew to $5.35 billion from $4.71 billion in the year-ago period, also topping analysts’ forecast.

Same-store sales for both its owned and licensed stores grew 12.4% compared with the prior year. Analysts polled by Refinitiv had been looking for a 13.3% increase.

This story is developing. Please check back for updates.

Articles You May Like

Abbott Labs’ surprise guidance bump is a major positive for its shareholders
Immigration, Retirement, And A New Middle Market Hiding In Plain Sight
Top Wall Street analysts pick these 3 dividend stocks for higher returns
What Will Happen If The Social Security Trust Funds Run Out?
Meet the private doctor to the wealthy — at $40,000 a year

Leave a Reply

Your email address will not be published. Required fields are marked *